Burning Rock Biotech Limited (BNR)

NASDAQ · Health care · Services-Medical Laboratories · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), Burning Rock Biotech Limited reported revenue of CN¥539.6M and net income of −CN¥55.3M. Annual financial statements are available for fiscal years 2018 to 2025, taken from the company's filings with the SEC.

Open interactive financials →

Key financials

CNY	FY2025 2025-12-31	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31
Income statement
Revenue	CN¥539.6M	CN¥515.8M	CN¥537.4M	CN¥563.2M	CN¥507.9M
Gross profit	CN¥402.9M	CN¥362.4M	CN¥363.2M	CN¥380.0M	CN¥364.1M
Operating income	−CN¥54.8M	−CN¥357.6M	−CN¥669.3M	−CN¥980.4M	−CN¥797.1M
Net income	−CN¥55.3M	−CN¥346.6M	−CN¥653.7M	−CN¥971.2M	−CN¥796.7M
Diluted EPS	–	–	–	–	CN¥0.00
Cash flow
Operating cash flow	−CN¥28.4M	−CN¥92.3M	−CN¥255.8M	−CN¥456.8M	−CN¥477.9M
Capital expenditure	CN¥5.2M	CN¥5.4M	CN¥8.1M	CN¥62.0M	CN¥204.3M
Free cash flow	−CN¥33.7M	−CN¥97.7M	−CN¥263.9M	−CN¥518.8M	−CN¥682.2M
Balance sheet
Cash and equivalents	CN¥478.4M	CN¥519.8M	CN¥615.1M	CN¥905.5M	CN¥1.43B
Total assets	CN¥820.4M	CN¥885.3M	CN¥1.04B	CN¥1.59B	CN¥2.28B
Total liabilities	CN¥285.1M	CN¥304.5M	CN¥271.6M	CN¥429.1M	CN¥433.3M
Total debt	CN¥1.7M	CN¥0	–	CN¥0	CN¥0
Shareholders' equity	CN¥535.3M	CN¥580.8M	CN¥768.4M	CN¥1.16B	CN¥1.85B

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in CNY as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full BNR page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open BNR financials →